Venture philanthropy has become an increasingly significant source of capital for the earliest stages of company development in the life science space. Often looking to help bridge the gap between angel and venture capital financing, these groups have improved patient outcomes as their bottom line and look to use their financial returns from investments to improve that metric further. Financing is far from the only thing venture philanthropy groups can bring to an early stage company; they can often supply access to patients and experts in their field, access to tissue banks, and connections to donors.
At RESI in Boston this Sept. 16th we will be bringing together 5 experts in the venture philanthropy space to discuss the various ways that they can work with and help early stage life science companies.
In a panel moderated by Chris de Souza, Director of Broadview Ventures, the audience will hear from:
- David Sandak, VP of Strategy and Research, Accelerate Brain Cancer Cure
- Daniel Smith, President, Autism Speaks
- Jit Patel, VP of Research and Business Development, JDRF [Juvenile Diabetes Research Foundation]
- Usha Arunachalam, VP Business Development for Research, Leukemia & Lymphoma Society
If venture philanthropy investment is part of the plan to get your company funded or to its next inflection point, this panel presents a great opportunity to broaden your network while expanding your understanding of these organizations.